Franz Obermayr's Location
Austria
Franz Obermayr's Work
Franz Obermayr's Education
Max Plank Institute for Immunobiology
PostDoc
1996 - 1998
Imperial Cancer Research Fund
PhD (Genetics)
1992 - 1996
Paris Lodron Universität Salzburg
1987 - 1992
Franz Obermayr's Skills
Franz Obermayr's Summary
Franz Obermayr, based in Austria, is currently a CEO at EPICS Therapeutics, bringing experience from previous roles at EyeGate Pharma (Nasdaq:EYEG), Panoptes Pharma and Nabriva Therapeutics AG. Franz Obermayr holds a 1996 - 1998 PostDoc @ Max Plank Institute for Immunobiology. With a robust skill set that includes Cinical and preclinical deelopment of small molecules and antibodies, Project managment, CRO managment, Regulatory expertise, CRO, Small Molecules, Clinical Development and more, Franz Obermayr contributes valuable insights to the industry. Franz Obermayr has 2 emails on RocketReach.